Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells.

Zhijun, Huang

Pre-clinical characterization of 4SC-202, a novel class I HDAC inhibitor, against colorectal cancer cells. [electronic resource] - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Aug 2016 - 10257-67 p. digital

Publication Type: Journal Article

1423-0380

10.1007/s13277-016-4868-6 doi


Animals
Antineoplastic Agents--pharmacology
Apoptosis--drug effects
Benzamides--pharmacology
Blotting, Western
Cell Line, Tumor
Cell Proliferation--drug effects
Colorectal Neoplasms--pathology
Enzyme-Linked Immunosorbent Assay
Flow Cytometry
Gene Knockdown Techniques
Histone Deacetylase Inhibitors--pharmacology
Humans
Mice
Mice, Inbred C57BL
Mice, Nude
Xenograft Model Antitumor Assays